Cabot (CBT) to Release Earnings on Monday

Cabot (NYSE:CBT) is anticipated to post its Q3 2025 quarterly earnings results after the market closes on Monday, August 4th. Analysts expect Cabot to post earnings of $1.80 per share and revenue of $957.29 million for the quarter. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.86 by $0.04. Cabot had a net margin of 11.08% and a return on equity of 26.76%. The company had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the business posted $1.78 EPS. The firm’s revenue was down 8.1% on a year-over-year basis. On average, analysts expect Cabot to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cabot Trading Down 0.3%

NYSE CBT opened at $71.99 on Friday. The company has a quick ratio of 1.30, a current ratio of 1.96 and a debt-to-equity ratio of 0.69. Cabot has a 52 week low of $70.40 and a 52 week high of $117.46. The stock has a market capitalization of $3.87 billion, a PE ratio of 9.31 and a beta of 0.87. The firm has a 50 day moving average of $75.72 and a two-hundred day moving average of $80.00.

Cabot Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 11th. Shareholders of record on Friday, August 29th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.5%. Cabot’s dividend payout ratio (DPR) is presently 23.29%.

Analyst Ratings Changes

Several research analysts have commented on the stock. UBS Group lowered their price target on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating for the company in a report on Monday, April 7th. Wall Street Zen cut shares of Cabot from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of CBT. Goldman Sachs Group Inc. boosted its holdings in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after buying an additional 108,645 shares in the last quarter. Empowered Funds LLC boosted its holdings in shares of Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after buying an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after buying an additional 4,048 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Cabot in the 1st quarter valued at $96,000. Finally, NewEdge Advisors LLC boosted its holdings in shares of Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock valued at $82,000 after buying an additional 947 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.